Testing of the Topoisomerase 1 Inhibitor Genz644282 by the Pediatric Preclinical Testing Program

BACKGROUND: Genz644282 is a novel non-camptothecin topoisomerase I poison that is in clinical development. PROCEDURES: Genz644282 was tested against the PPTP in vitro panel (0.1 nM–1 μM), and in vivo using three times per week × 2 schedule repeated at day 21 at its maximum tolerated dose (MTD) of 4...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Houghton, Peter J., Lock, Richard, Carol, Hernan, Morton, Christopher L., Gorlick, Richard, Kolb, E. Anders, Keir, Stephen T., Reynolds, C. Patrick, Kang, Min H., Maris, John M., Billups, Catherine A., Zhang, Mindy X., Madden, Stephen L., Teicher, Beverly A., Smith, Malcolm A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3154998/
https://ncbi.nlm.nih.gov/pubmed/21548007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.23016
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky